Cleveland BioLabs, Inc. (NASDAQ: CBLI) 25.4% HIGHER; entered into a definitive stock purchase agreement with an accredited investor, David Davidovich ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Cree (CREE) Announces Restructuring of LED; Canaccord Genuity Cuts Price Target to $28June 25, 2015 9:21 AM Cree (CREE) Continues to see LED Pricing Pressure; UBS Cuts Price Target to $30.50 June 25, 2015 9:00 AM UBS Cuts the Price Target on Bed Bath & Beyond (BBBY) Following 1Q16 Results June 25, 2015 8:17 AM Cowen Cuts Price Target on Cree (CREE) Following Announced LED Restructure June 25, 2015 7:50 AM Oppenheimer Maintains Perform Rating Following Announcements made by Cree (CREE) June 25, 2015 7:12 AM